All Stories

  1. The ERSPC Study: Quality Takes Time and Perseverance

    Article • Clinical Chemistry, November 2018, AACC

    Dr Monique Roobol

  2. Personalized schedules for surveillance of low-risk prostate cancer patients

    Article • Biometrics, July 2018, Wiley

    Dr Monique Roobol

  3. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis

    Article • BJU International, June 2018, Wiley

    Dr Monique Roobol

  4. The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

    Article • BJU International, January 2018, Wiley

    Dr Monique Roobol

  5. Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7

    Article • Histopathology, January 2018, Wiley

    Dr Monique Roobol

  6. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials

    Article • Cancer, December 2017, Wiley

    Dr Monique Roobol

  7. Summary statement on screening for prostate cancer in Europe

    Article • International Journal of Cancer, October 2017, Wiley

    Dr Monique Roobol

  8. Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator

    Article • International Journal of Urology, September 2017, Wiley

    Dr Monique Roobol

  9. Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

    Article • BJU International, June 2017, Wiley

    Dr Monique Roobol

  10. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance

    Article • The Prostate, May 2017, Wiley

    Dr Monique Roobol

  11. The need for active surveillance for low risk prostate cancer

    Article • Expert Review of Anticancer Therapy, April 2017, Taylor & Francis

    Dr Monique Roobol

  12. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer

    Article • BJU International, April 2017, Wiley

    Dr Monique Roobol

  13. Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam

    Article • International Journal of Urology, February 2017, Wiley

    Dr Monique Roobol

  14. prostate cancer screening and mortality

    Article • BJU International, May 2016, Wiley

    Dr Monique Roobol